Evidence map›Paper›PMID 33999373›Full record

ArticleJournal of cardiovascular translational research2021

Copper Preserves Vasculature Structure and Function by Protecting Endothelial Cells from Apoptosis in Ischemic Myocardium.

Ying Xiao, Xin Song, Tao Wang, Xia Meng, Qipu Feng, Kui Li, Y James Kang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cardiovascular translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. The Yin and Yang of copper in cardiovascular health and disease.Molecular and cellular biochemistry · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ying Xiao *Regenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, Sichuan, 610041, People's Republic of China.
Xin Song *Regenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, Sichuan, 610041, People's Republic of China.
Tao WangRegenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, Sichuan, 610041, People's Republic of China.
Xia MengRegenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, Sichuan, 610041, People's Republic of China.
Qipu FengRegenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, Sichuan, 610041, People's Republic of China.
Kui LiRegenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, Sichuan, 610041, People's Republic of China.
Y James KangRegenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, Sichuan, 610041, People's Republic of China. ykang7@uthsc.edu.ORCID 0000-0001-8449-7904
Sichuan University · CNUniversity of Tennessee Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study was undertaken to investigate whether Cu protects vasculatures from ischemic injury in the heart. C57/B6 mice were introduced to myocardial ischemia (MI) by permanent ligation of the left anterior descending (LAD) coronary artery. Two hours post-LAD ligation, mice were intravenously injected with a Cu-albumin (Cu-alb) solution, or saline as control. At 1, 4, or 7 days post-MI, hearts were collected for further analysis. A dramatic decrease in CD31-positive endothelial cells concomitantly with abundant apoptosis, along with obstruction of blood flow, was observed in ischemic myocardium 1 day post-MI. The early Cu-alb treatment protected CD31-positive cells from apoptosis, along with a preservation of micro-vessels and a decrease in infarct size. This early vasculature preservation ensured myocardial blood perfusion and protected cardiac contractile function until 28 days post-MI. This strategy of Cu-alb treatment immediately following MI would help develop a therapeutic approach for acute heart attack patients in a clinical setting.

Indexed as

AnimalsApoptosisCopperDisease Models, AnimalEndothelial CellsEndothelium, VascularMaleMiceMice, Inbred C57BLMyocardial IschemiaCopperCD31CopperEndothelial cellsMyocardial ischemiaMyocardial vasculature

Identifiers

PMID33999373
OpenAlexW3163660952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.